A revolutionary high-voltage neural stimulator in standard CMOS technology enables smaller, safer biomedical implants for treating neurological disorders.
Imagine a medical device so tiny it fits on your fingertip, yet powerful enough to treat Parkinson's disease, depression, or chronic pain. This isn't science fiction—it's the reality of modern neural stimulation technology, where microscopic electrical pulses can reboot malfunctioning brain circuits. For millions suffering from neurological disorders, these implanted devices offer hope when medications fail. But there's been a persistent challenge: how to generate the necessary therapeutic power within the strict size and safety constraints of devices meant to reside inside the human body.
Traditional approaches rely on bulky batteries or inefficient circuits that limit miniaturization.
Nerve tissue needs 8-12V for stimulation, but standard chips handle only 1.8-3.3V without damage.
Recent research from Shanghai University presents a breakthrough—a neural stimulation circuit that generates 12.69 volts from just 1.65 volts using an innovative design that eliminates the need for special high-voltage manufacturing processes 1 . This advance could lead to smaller, safer, and more sophisticated implantable devices.
Our nervous system operates on a delicate balance of electrical and chemical signals. In conditions like Parkinson's disease, essential neurons degenerate, causing movement tremors, stiffness, and balance problems. With epilepsy, neurons fire in uncontrolled synchrony, generating seizures. Depression often involves disrupted signaling in mood-regulating circuits. Neural stimulation works by interrupting these faulty patterns with precisely timed electrical pulses, essentially resetting misbehaving neural networks to their proper rhythm 1 .
The electrode-tissue interface where stimulation occurs presents a significant barrier. The electrical impedance (resistance to current flow) at this junction can range from tens of thousands to millions of ohms 1 . To drive a sufficient current through this resistance to activate neurons—typically around 1 milliamp—the stimulator must generate substantial voltage. Basic physics (Voltage = Current × Resistance) reveals the problem: even at a modest 10,000 ohm impedance, 1 milliamp of current requires 10 volts.
Visualization of electrical pulses traveling through neural tissue
At the heart of this innovation lies a clever reimagining of a classic concept: the capacitor-based charge pump. Traditional charge pumps work like microscopic bucket brigades, passing electrical charge from one capacitor to another to build up voltage. The conventional Dickson charge pump—used for decades—employs numerous diode-connected transistors that create significant voltage drops at each stage, reducing efficiency and requiring more stages to reach high voltages 1 .
The new design introduces two key improvements that dramatically enhance performance:
This innovative architecture achieves what engineers have pursued for years: it reduces the number of required stages by three compared to conventional designs, saving approximately 29% of the circuit area while simultaneously improving power efficiency 1 .
Uses diodes/MOSFETs with significant voltage drops at each stage
Creates negative baseline voltage to prime the pumping process
Reconfigures capacitors between charging and transfer phases
29% smaller area with improved power efficiency
| Feature | Traditional Dickson Pump | New Series-Parallel with Negative Voltage Assist |
|---|---|---|
| Stages needed for 12V output | 7 stages | 4 stages |
| Circuit area | Larger (100% reference) | 29% smaller |
| Key components | Diodes/MOSFETs | Capacitors with negative voltage assist |
| Efficiency limitations | Diode voltage drops | Reduced switch losses |
| Integration compatibility | Requires special processes | Works with standard low-voltage CMOS |
Generating high voltages on a chip designed for low-voltage operation creates another critical challenge: preventing electrical breakdown that could instantly destroy the delicate transistors. The research team addressed this using a stacked transistor structure with deep N-well isolation 1 .
This approach works like a multi-story parking garage where each level contains the same cars but remains structurally separate. The circuit uses the multiple voltage levels generated by the charge pump (Vout1 to Vout4) to create different voltage domains that ensure no single transistor experiences excessive voltage stress 1 . Sophisticated bootstrap clock generation circuits produce carefully timed control signals that coordinate this complex operation while protecting all components 1 .
Deep N-well isolation prevents electrical breakdown in low-voltage transistors
To validate their design, the research team implemented the complete neural stimulation system—including the high-voltage generation circuit, output driver, and constant-current source—using a standard 180 nanometer CMOS process 1 , the workhorse technology for many modern chips. This choice demonstrates the practical viability of their approach using accessible manufacturing technology.
The testing process evaluated several critical performance aspects:
The team used sophisticated electronic design automation tools to simulate the circuit's behavior under various operating conditions, verifying both functionality and reliability before actual fabrication.
180nm standard process used for implementation
Electronic design automation tools for verification
The simulation results demonstrated remarkable achievements that address the fundamental challenges of implantable neural stimulators:
Output voltage from just 1.65V input 1
Power efficiency in high-voltage generation 1
Maximum output current for neural stimulation 1
| Parameter | Result | Significance |
|---|---|---|
| Output Voltage | 12.69 V | Sufficient for neural stimulation through typical electrode-tissue interfaces |
| Maximum Output Current | 1 mA | Meets requirement for effective neural stimulation 1 |
| Power Efficiency (HV generation) | 74.9% | Minimal energy waste, crucial for battery-operated implants |
| Standby Power | 66 pW | Extremely low power between treatments extends battery life |
| CMOS Process | 180 nm | Uses standard, affordable chip manufacturing technology |
| Component/Technique | Function/Role | Note on Innovation |
|---|---|---|
| 180 nm CMOS process | Standard semiconductor manufacturing technology | Eliminates need for special high-voltage devices 1 |
| Series-parallel charge pump | Voltage multiplication beyond supply limits | Negative voltage assist reduces stages by 3 1 |
| Deep N-well transistors | Protection from high-voltage damage | Enables use of low-voltage transistors in high-voltage application 1 |
| Bootstrap clock circuits | Generation of control signals for switches | Ensures all transistors operate within safe voltage limits 1 |
| Constant-current source | Delivers precise stimulation current | Maintains safety by controlling charge injection into tissue 1 |
| Stacked transistor output | High-voltage signal generation using low-voltage parts | Four voltage levels create safe domains for each transistor 1 |
This research breakthrough extends far beyond laboratory measurements. By solving the fundamental challenge of efficient high-voltage generation in standard CMOS technology, it opens doors to previously impossible medical treatments and significantly improved versions of existing therapies.
Smaller, safer deep brain stimulation implants with longer battery life
Miniaturized devices with improved sound quality and resolution
Closed-loop systems that detect and prevent seizures before they occur
Perhaps most excitingly, this work contributes to the development of complete closed-loop brain-computer interface systems 1 —devices that can both read neural signals and write therapeutic patterns, adapting in real-time to the brain's changing needs. Such systems could eventually treat conditions ranging from depression to spinal cord injuries, offering hope to millions worldwide.
The achievement demonstrates how innovative thinking can overcome seemingly fundamental physical limitations. By reimagining capacitor-based charge pumps and protection structures, the researchers have given us a glimpse into the future of bioelectronic medicine—one where sophisticated neural interfaces operate reliably for decades inside the human body, quietly correcting faulty circuitry and restoring what disease has taken away.
As this technology progresses from simulation to actual implementation and eventually to clinical use, it represents another step toward seamlessly integrating advanced electronics with the human nervous system—not to create cyborgs, but to heal, to restore, and to affirm our growing ability to repair the body's most complex system when it falters.